Bio Path reported $4K in Ordinary Share Capital for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Baxter International BAX:US $ 683M 0M
Bio Path BPTH:US $ 0M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Karyopharm Therapeutics KPTI:US $ 7K 0
Seattle Genetics SGEN:US $ 0.18M 0.01M
Spectrum Pharmaceuticals SPPI:US $ 0.15M 0.03M